Genpact Limited (G): What Does Valuation Ratios Tell Us?

Genpact Limited (NYSE:G) saw a downside of -1.79% to $35.59 after subtracting -$0.65 on Tuesday. The 5-day average trading volume is 885,643 shares of the company’s common stock. It has gained $37.03 in the past week and touched a new high 1 time within the past 5 days. An average of 1,116,961 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,270,466.

G’s 1-month performance is -5.22% or -$1.83 on its low of $35.31 reached on 08/08/23. The company’s shares have touched a 52-week low of $35.75 and high of $48.85, with the stock’s rally to the 52-week high happening on 02/23/23. YTD, G has lost -23.16% or -$10.68 and has reached a new high 10 times. However, the current price is down -27.14% from the 52-week high price.

Insider Transactions

G stock investors last saw insider trading activity on Jun 02.Mehta Piyush (Senior Vice President and CHRO) most recently sold 29,491 shares at $37.18 per share on Jun 02. This transaction cost the insider $1,096,469. Senior Vice President and CHRO, Mehta Piyush, sold 41,062 shares at a price of $37.02 on Jun 01. Then, on May 31, Senior Vice President and CHRO Mehta Piyush sold 10,337 shares at a price of $37.00 per share. This transaction amounted to $382,483.

Valuation Metrics

G stock has a beta of 1.19. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.49 while the price-to-book (PB) in the most recent quarter is 3.40, with the price to cash flow ratio at 17.28.

Genpact Limited’s quick ratio for the period ended March 30 was 1.80, with the current ratio over the same period at 1.80. As well, the company’s long term debt to equity for the quarter ending March 30 was 0.65, while the total debt to equity was 0.76. In terms of profitability, the gross margin trailing 12 months is 34.70%. The trailing 12-month EBITDA margin is 15.53% while for the period ending March 30, Genpact Limited’s operating margin was 11.70%. The firm’s gross profit as reported stood at $1.54 billion against revenue of $4.37 billion.

Earnings Surprise

For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 9.35% to $106.1 million, while revenue of $89.71 million was 15.45% off the previous quarter. Analysts expected G to announce $0.65 per share in earnings in its latest quarter, but it posted $0.68, representing a 4.60% surprise. EBITDA for the quarter stood at more than $172.61 million. G stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 2.58 billion, with total debt at $1.7 billion. Shareholders hold equity totaling $184.15 million.

Let’s look briefly at Genpact Limited (G) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 31.62% to suggest the stock is trending Neutral, with historical volatility in this time period at 32.41%.

The stock’s 5-day moving average is $36.22, reflecting a -3.55% or -$1.31 change from its current price. G is currently trading -6.80% above its 20-day SMA, -18.31% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -4.68% and SMA200 by-21.10%.

Stochastic %K and %D was 7.73% and 9.42% and the average true range (ATR) pointed at 0.85. The RSI (14) points at 36.05%, while the 14-day stochastic is at 7.99% with the period’s ATR at 0.85. The stock’s 9-day MACD Oscillator is pointing at -0.44 and -1.09 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Genpact Limited (NYSE: G), Citigroup downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for G stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate G as a “sell,”, while 7 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 3 have offered a “buy” rating.

What is G’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $41.00 and a high of $56.00, with their median price target at $46.00. Looking at these predictions, the average price target given by analysts is for Genpact Limited (G) stock is $47.00.

Most Popular

Related Posts